Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
4.440
+0.080 (1.83%)
At close: Sep 18, 2025, 4:00 PM EDT
4.244
-0.196 (-4.41%)
After-hours: Sep 18, 2025, 7:34 PM EDT
SHPH Employees
Shuttle Pharmaceuticals Holdings had 9 employees as of December 31, 2024. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,349,114
Market Cap
4.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 1 | 14.29% |
| Dec 31, 2022 | 7 | 2 | 40.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | -1 | -16.67% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SHPH News
- 5 weeks ago - Shuttle Pharma Provides Second Quarter 2025 Corporate Update - GlobeNewsWire
- 3 months ago - Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 3 months ago - Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market - GlobeNewsWire
- 3 months ago - Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time - GlobeNewsWire
- 3 months ago - Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative - GlobeNewsWire
- 3 months ago - Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors - GlobeNewsWire
- 4 months ago - Shuttle Pharma Provides Corporate Update - GlobeNewsWire
- 4 months ago - Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial - GlobeNewsWire